Welcome to Bulios, a community platform that guides you through the world of stocks and investments. Join us.
Filter
Are you buying into $NVDA-1.6%stock or do you think there will be even more room to fall under the U.S. investigation?
It doesn't look good with Intel at all. Since the beginning of the year, the stock is down nearly 60%, which is quite a bump. I don't have $INTC+3.3% stock in my portfolio, and I don't want it.
What's your take on the Intel situation?
Intel
INTCZobrazit další komentáře
I'm thinking about buying it, as it's a great discount and an interesting opportunity.
Shares of $BTI-0.3% and $MO+0.3% formed new ATH today. Both stocks are up over 25% year to date and also pay a dividend of over 7%. I had both $BTI-0.3% and $MO+0.3%in my portfolio until the beginning of the summer . I sold $BTI-0.3% and kept $MO+0.3% as I trust Altria and don't need more than $BTI-0.3% and two tobacco stocks in my portfolio.
PennantPark Floating Rate Capital: Stable returns in an uncertain environment
1. Introduction:
- PennantPark Floating Rate Capital $PFLT-0.9%: The company is a business development company (BDC) that provides high-interest loans to mid-sized businesses that traditional banks do not target. This focus allows it to choose borrowers who have a solid ability to repay their debts.
2...
Read more
Zobrazit další komentáře
It's a nicely built business and the dividend is great too, but I guess I'm not interested enough in this company to include their stock in my portfolio.
Apple teams up with Airtel to fight for Indian music and TV streaming market
- Strategic Partnership: $AAPL-0.3% has partnered with Bharti Airtel, India's second largest telecom company, to gain a competitive advantage in the digital content market in India.
- Free streamingAirtel : The deal includes free music and video streaming for many of Airtel's 281 million customers, which...
Read more
The anti-obesity drug industry was in 2023 valued at $5.6 billion and will exhibit a CAGR of 27% between 2024 and 2032 (expert opinion).
$LLY+0.7%, $NVO-5.5% and others are creating drugs like - Ozempic, Wegovy, Mounjaro and Zepbound - These are blockbusters in terms of weight loss market in my opinion. But which companies may have the best chance to take the biggest bite of...
Read more
Zobrazit další komentáře
For me ro are both great companies. I wouldn't be afraid to include them in my portfolio. At what price would you buy $LLY+0.7%?
The stock could still fall.